A. Klara Dickinson's Insider Trades & SAST Disclosures
A. Klara Dickinson's most recent trade in Cymabay Therapeutics Inc was a trade of 328,299 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 22, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Klara Dickinson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 328,299 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 215,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 200,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 175,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 138,312 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 100,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 78,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 66,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 21,000 | 0 (0%) | 0% | - | Common Stock | |
| Cymabay Therapeutics Inc | Klara Dickinson A. | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 78,000 | 78,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | A. Klara Dickinson | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 21,000 | 21,000 (0%) | 0% | 0 | Common Stock | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 215,000 | 215,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 66,500 | 66,500 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Klara A. Dickinson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 328,299 | 328,299 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges